Machine Learning: Transforming Drug Discovery and Development

12:45 PM - 1:30 PM (EDT), Monday, June 14, 2021
Search General Info
Search Education
Search Partnering Companies

Machine learning has the potential to help scientists transform several elements of disease research and drug discovery. Experts will discuss how machine learning techniques can be applied to different aspects of the drug discovery and development process, trade insights around problems and data sets that are particularly amenable to ML approaches, and address frameworks for potential collaboration.

Sponsored By
Moderator
photo
Senior Partner, Chief Business Development Officer
Flagship Pioneering
Speakers
photo
Partner
Lux Capital
photo
Co-Founder and CEO
Reverie Labs
photo
Genentech Head of Business Development, Tech Platforms, Pharma Partnering
Genentech and Roche
photo
Associate Professor, Systems Biology
Harvard Medical School